It is estimated that about 107 million people in China suffer from chronic sinusitis, about 1/3 of ... Nucala for chronic obstructive pulmonary disease or smoker's lungs. The trial met its primary ...
GSK's Nucala approved in China for CRSwNP, affecting 1/3 of 107 million sinusitis patients ... and/or surgery do not provide adequate disease control. The FDA approved Nucala for the same ...
Symptoms of sinusitis (fever, cough, nasal obstruction, nasal secretion and headache) were assessed at baseline and at follow-up visits, and classified as 'absent', 'mild' or 'severe' by the ...
In response, China’s National Disease Control and Prevention Administration ... is a respiratory virus that commonly causes mild to moderate flu-like symptoms. It is most prevalent during ...